More specifically, AML exosomes present RNAs whose transcripts are implicated in AML pathogenesis, prognosis (NPM1, FLT3-ITD), response to therapy (CXCR4, IGFIR), and leukemic niche formation (IGF-IR, CXCR4, MMP9) [145]. The gene discussed is NPM1; the disease is acute myeloid leukemia.